Bank of New York Mellon Corp Decreases Stake in Zoetis Inc. $ZTS

Bank of New York Mellon Corp decreased its holdings in Zoetis Inc. (NYSE:ZTS) by 24.3% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 3,720,914 shares of the company’s stock after selling 1,196,514 shares during the quarter. Bank of New York Mellon Corp owned about 0.84% of Zoetis worth $544,444,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. North Star Asset Management Inc. grew its stake in shares of Zoetis by 4.9% during the 2nd quarter. North Star Asset Management Inc. now owns 1,441 shares of the company’s stock worth $225,000 after purchasing an additional 67 shares during the period. Moment Partners LLC boosted its holdings in Zoetis by 3.2% during the second quarter. Moment Partners LLC now owns 2,354 shares of the company’s stock worth $367,000 after buying an additional 72 shares in the last quarter. CVA Family Office LLC grew its position in Zoetis by 6.7% during the second quarter. CVA Family Office LLC now owns 1,173 shares of the company’s stock worth $183,000 after buying an additional 74 shares during the period. Bank of Nova Scotia Trust Co. increased its holdings in Zoetis by 4.6% in the second quarter. Bank of Nova Scotia Trust Co. now owns 1,692 shares of the company’s stock valued at $264,000 after buying an additional 74 shares in the last quarter. Finally, Country Club Bank lifted its position in shares of Zoetis by 1.5% during the 2nd quarter. Country Club Bank now owns 5,142 shares of the company’s stock valued at $803,000 after acquiring an additional 75 shares during the period. Institutional investors and hedge funds own 92.80% of the company’s stock.

Wall Street Analysts Forecast Growth

ZTS has been the topic of several research analyst reports. UBS Group decreased their price target on Zoetis from $158.00 to $141.00 and set a “neutral” rating on the stock in a research note on Wednesday, November 5th. Wall Street Zen raised Zoetis from a “hold” rating to a “buy” rating in a report on Friday, January 23rd. HSBC set a $140.00 price target on Zoetis in a research report on Wednesday, December 10th. KeyCorp started coverage on shares of Zoetis in a research report on Thursday, November 20th. They issued a “sector weight” rating on the stock. Finally, Bank of America downgraded shares of Zoetis from a “buy” rating to a “neutral” rating and set a $135.00 target price for the company. in a report on Monday, December 15th. Five research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $152.91.

Zoetis Trading Down 2.4%

Shares of ZTS stock opened at $121.95 on Thursday. The company has a market capitalization of $53.74 billion, a price-to-earnings ratio of 20.53, a PEG ratio of 2.17 and a beta of 0.97. The company has a current ratio of 3.64, a quick ratio of 2.28 and a debt-to-equity ratio of 1.31. The firm has a 50-day moving average price of $123.91 and a 200 day moving average price of $137.58. Zoetis Inc. has a twelve month low of $115.25 and a twelve month high of $177.40.

Zoetis (NYSE:ZTS) last issued its quarterly earnings results on Tuesday, November 4th. The company reported $1.70 EPS for the quarter, topping analysts’ consensus estimates of $1.62 by $0.08. The business had revenue of $2.40 billion during the quarter, compared to the consensus estimate of $2.42 billion. Zoetis had a net margin of 28.21% and a return on equity of 57.19%. The company’s quarterly revenue was up .5% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.58 earnings per share. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Research analysts forecast that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 3rd. Investors of record on Tuesday, January 20th will be paid a $0.53 dividend. The ex-dividend date is Tuesday, January 20th. This is an increase from Zoetis’s previous quarterly dividend of $0.50. This represents a $2.12 annualized dividend and a yield of 1.7%. Zoetis’s payout ratio is currently 35.69%.

Zoetis Company Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.